8-K: Safety Shot Announces Positive Results from Human Clinical Trial, Confirming Rapid Alcohol Reduction and Hangover Prevention

Safety Shot, Inc. announces the peer-reviewed publication of a clinical trial demonstrating statistically significant reductions in blood alcohol concentration and hangover symptoms compared to a placebo.

Summary

• Safety Shot, Inc. announced the publication of a peer-reviewed clinical trial in the Journal of Nutrition and Dietary Supplements.
• The study demonstrated that Safety Shot significantly reduces blood alcohol concentration (BAC), breath alcohol concentration (BrAC), and hangover symptoms compared to a placebo (p < 0.05).
• The study showed that Safety Shot reduced blood alcohol levels in as little as 30 minutes.
• Trial participants reported less head discomfort, reduced fatigue, increased energy levels, improvements in concentration, and reduced feelings of tiredness compared to the placebo.
• Participants in the Safety Shot group had greater urine output, particularly at the 60-minute mark.
• The global market for hangover cure products is projected to grow at a compound annual growth rate (CAGR) of 14.1% from 2023 to 2030, reaching over $6 billion by 2032.

Sentiment

Score: 8

Explanation: The document presents positive clinical trial results and market growth projections, suggesting a favorable outlook for the company. The tone is optimistic and confident.

Positives

• The clinical trial results are peer-reviewed and published in a reputable journal.
• Safety Shot demonstrated a statistically significant reduction in BAC and BrAC.
• Participants reported improvements in hangover symptoms, including reduced head discomfort and fatigue.
• The company is targeting a rapidly growing market for hangover cure products.
• Safety Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon.

Negatives

• The study involved a small amount of alcohol consumption due to ethical and legal limitations.
• The study protocol was not limited to specific demographics as defined by age, sex, anthropometric disposition or frequency and tolerance of alcohol consumption.

Risks

• The company faces competition in the growing market for hangover cure products.
• Ethical and legal limitations restricted the amount of alcohol consumed in the clinical trial.

Future Outlook

Safety Shot, Inc. is introducing business-to-business sales of Sure Shot to distributors, retailers, restaurants, and bars throughout 2025, and is strategically positioned to capture a significant share of the burgeoning market.

Management Comments

• 'Alcohol consumption may have implications in multiple settings, but the results of this study show that there are solutions available – over the counter – that can mitigate its effects and dangers and allow for a more positive overall experience,' said Jarrett Boon, Safety Shot CEO.
• Jarrett Boon stated that the company's commitment to scientific research has culminated in a groundbreaking achievement.
• Dr. Tim Ziegenfuss, CEO of CAHS, stated that the results are highly encouraging, showcasing Safety Shot's potential as a beneficial supplement for individuals consuming alcohol.

Industry Context

The announcement highlights Safety Shot's entry into the rapidly expanding global market for hangover cure products, which is projected to grow significantly in the coming years. The company is positioning itself as a leader in this market through its clinically proven efficacy and unique human-based research.

Comparison to Industry Standards

• The company claims that this is the first-ever human clinical trial to demonstrate the efficacy of a dietary supplement blend in reducing the acute effects of alcohol.
• Previous research has primarily relied on animal models, which may not translate directly into human physiology.

Stakeholder Impact

• Shareholders may react positively to the clinical trial results and market growth projections.
• Customers may benefit from the availability of a clinically proven product to reduce the negative effects of alcohol consumption.

Next Steps

• Safety Shot, Inc. is introducing business-to-business sales of Sure Shot to distributors, retailers, restaurants, and bars throughout 2025.

Key Dates